Heraldnet.com
SATURDAY, NOVEMBER 22, 2008 9:22 am
LocalNorthwestNation & WorldPoliticsSpecial ReportsPhotosColumnistsMultimedia 
Blog
Michelle Dunlop
Boeing, Northrop tanker news
Your town news
Mike Benbow
Business editor Mike Benbow's insights into all things business.
•Latest: Expert advice for small businesses trying to cope
Steve Tytler
Steve Tytler answers your questions about real estate.
•Latest: Get right side up by modifying home loan
 
WEEK IN REVIEW
Friday


'Twilight' brings out crowds after dark
The Wii teaches P.E. at Arlington high school
State's tobacco cash helps smokers kick habit
Thursday


For old ferries, it's the end of the line
Tribal leaders accused of smoke-shop tax scam
'I blew her away,' girl's father told police
Wednesday


Kimberly-Clark keeps closer eye on its Everett ...
Owners protest Monroe plan for 'potentially dan...
Marysville man charged in fatal shooting of 6-y...
Tuesday


Girl, 6, fatally shot; father jailed
Century-old Arlington house succumbs to flames
In Snohomish and other cities, sales tax revenu...
Monday


Economy forces teens to cope with smaller allow...
Tax hike sought to clean up Puget Sound
Oso residents want to use old school as communi...
Sunday


Monroe may toughen rules for some dog breeds
County preparations kept flood rescues to minimum
It's playtime, maties
Saturday


A mom and dad of her own
Deal likely to avert strike of Boeing engineers
Sultan eliminates its police department
 

ADVERTISEMENT

Business   Print This Article  Email This Page  Subscribe Now! facebook digg reddit del.icio.us fark stumble

 
ADVERTISEMENT

 
CONTACT THE HERALD
Mike Benbow, Business Editor
benbow@heraldnet.com
 
Published: Friday, April 25, 2008

Seattle Genetics plans more clinical drug tests

BOTHELL -- Seattle Genetics earned more money from its big drug development partner during the first quarter, but the biotechnology firm's losses nearly doubled as expenses rose.

The Bothell-based developer of cancer drugs posted a net loss of $17.1 million, or 22 cents a share, compared to an $8.8 million loss in the year-ago period.

Clay Siegall, Seattle Genetics' president and chief executive officer, said the company's three leading drug candidates are moving well through clinical trials. Based on encouraging data, he said, the company is accelerating manufacturing and clinical development activities to further advance those drugs.

"We now have 10 trials ongoing across our portfolio and two more planned to start this year," Siegall said.

The company's lead drug candidate, SGN-40, is now in multiple trials. The start of its latest study triggered a $4 million payment from Genentech, which is helping Seattle Genetics develop the cancer drug.

That payment helped to push revenue during the period to $7.1 million, up from $4.3 million a year ago. Operating expenses totaled $26.1 million, up from $14.6 million because of expanded clinical trial costs. The company also has grown its research and development staff since last year.

But the biotech has plenty banked away to cover the costs, Siegall reported. As of March 31, Seattle Genetics had $216 million in cash and investments, which includes proceeds of $97.6 million from the company's public stock offering in January.

Reporter Eric Fetters: 425-339-3453 or fetters@heraldnet.com.

1. Boeing warns of job cuts during 2009
2. 160 Snohomish County jobs are on the chopping block
3. Steve & Barry's store to shut down at Everett Mall
4. 'Twilight' brings out crowds after dark
5. Stillaguamish ex-leaders plead guilty to cigarette trafficking
6. Chicken pox outbreak keeps 300 Monroe students at home
7. The Wii teaches P.E. at Arlington high school
8. From a tragedy comes a promise
9. Wilson's play finally catching up to his running mouth
10. Marysville police seek robber
Enterprise Newspaper Snohomish County Business Journal
Seattle Prep ends Shorecrest's title hopes
Deja vu: Seattle Christian thwarts King's title shot
Shoreline Christian's boys soccer title hopes dashed
Edmonds' Pink House staying put
King's wins first state volleyball title
RV in plain sight? City says 'That's illegal'
Timberwolves take Class 4A title
Mavs can't hang on against Capital
TV success shares life as artist, geek
The Enterprise Online Newspaper

TODAY'S TOP JOBS
 View All Top Jobs 
Top Cars
Top Homes


ADVERTISEMENT